Gastric cancer

Stomach cancer is an abnormal growth of malignant cells in the lining of the stomach. Stomach cancer, also known as gastric cancer, can affect any part of the stomach. In most countries of the world, stomach cancers form in the main part of the stomach (stomach body). The main risk factors are age, diet and pre-existing stomach disease.

Showing all 6 results

Filter our product list:
API
Antigen / Target
Therapeutic Areas
Therapeutic Indications
1
Classes of molecule​s
Isotypes
Expiry Date
CoA
Filters Sort results
Reset Apply

Product
Batch

Antigen
Molecular Class
Drug Brand
Product Concentration
CoA
Quantity per vial
Storage Temperature
Expiry Date
Price from
VEGFR2
Monoclonal Antibody
Cyramza®
10 mg/mL
2 mg
-80°C
03/2018
182,70 
view product
Max: 10
Min: 2
Step: 1
VEGFR2
Monoclonal Antibody
Cyramza®
10 mg/mL
2 mg
-80°C
06/2018
182,70 
view product
Max: 10
Min: 2
Step: 1
VEGFR2
Monoclonal Antibody
Cyramza®
10 mg/mL
2 mg
-80°C
08/2018
182,70 
view product
Max: 10
Min: 2
Step: 1
VEGFR2
Monoclonal Antibody
Cyramza®
10 mg/mL
2 mg
-80°C
01/2019
182,70 
view product
Max: 10
Min: 2
Step: 1
VEGFR2
Monoclonal Antibody
Cyramza®
10 mg/mL
2 mg
-80°C
12/2019
182,70 
view product
Max: 10
Min: 2
Step: 1
VEGFR2
Monoclonal Antibody
Cyramza®
10 mg/mL
2 mg
-80°C
06/2020
182,70 
view product
Max: 8
Min: 2
Step: 1

Not looking for Gastric cancer?

Search our therapeutic molecules product database